100+ investors are already onboard—your great project is the missing piece! 2026 Yitao Bio-Manufacturing Roadshow Registration Now Open
The synthetic biology-driven biomanufacturing industry is entering a golden period for technology commercialization.
Continuous iteration of medical beauty efficacy ingredients、Bio-based biodegradable materialsAlternative to traditional chemicals,New Protein FoodsAccelerate deploymentBio-agricultureScaled rollout of improved solutions, combinedAI Strain Design、Smart Fermentation ProcessDeep penetration across multiple sectors is driving concentrated breakthroughs in foundational technologies. However, many high-quality lab projects are stalled at the pilot-scale-up and commercialization stages. A vertical, efficient, and precise channel for connecting innovative assets with industrial capital remains missing.
On China's bio-manufacturing industry map,Shanghaihold an irreplaceable position
Policy LevelShanghai was the first to launch an action plan for the synthetic biology industry and integrate biomanufacturing into the modern industrial system of the "15th Five-Year Plan," with coordinated policy support from both municipal and district levels. In terms of industrial layout, Pudong Zhangjiang focuses on foundational innovation, while Jinshan and Baoshan host large-scale manufacturing, establishing a clear "one core, two wings" structure.
Research StrengthDeep roots: Home to China's first key laboratory and strategic innovation alliance in synthetic biology. The nation's first listed company in synthetic biology commercialization also originated here, with a stable supply of original innovations drawn from universities and research institutes.
Capital DimensionIn 2025, Shanghai launched its first bio-manufacturing industry fund with a scale of 10 billion yuan, continuously guiding patient capital toward technology commercialization projects.
Leveraging the concentration of innovation and technology resources, business exchanges, and financial elementsShanghaiTo become a key platform for connecting industry, academia, and research with capital in biomanufacturing, as well as for implementing cross-domain technologies; also leveragingYangtze River DeltaCollaborate across industries and leverage surrounding regions to scale pilot testing and mass manufacturing, continuously bridging the gap from lab innovation to industrial application.
2026 (2nd) Yimao Bio-Manufacturing Industry Conference & Exhibition (Summer) will be held in Shanghai from 8 to 28., as of now, there are already100+Investor confirmed attendanceThe institutional lineup includes strategic investment divisions of industrial conglomerates, top-tier hard-tech venture funds, state-owned science and technology innovation platforms, and specialized synthetic biology investors—delivering comprehensive coverage across all sub-sectors of the bio-manufacturing investment landscape.
Investor Attendee List (Partial)
